A detailed history of Glenmede Trust CO Na transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 20,245 shares of MEDP stock, worth $6.78 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,245
Previous 76,291 73.46%
Holding current value
$6.78 Million
Previous $31.4 Million 78.51%
% of portfolio
0.03%
Previous 0.16%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$320.58 - $457.29 $18 Million - $25.6 Million
-56,046 Reduced 73.46%
20,245 $6.75 Million
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $10.3 Million - $11.7 Million
27,655 Added 56.86%
76,291 $31.4 Million
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $4.01 Million - $5.82 Million
-14,079 Reduced 22.45%
48,636 $19.7 Million
Q4 2023

Feb 13, 2024

SELL
$227.52 - $312.68 $107,844 - $148,210
-474 Reduced 0.75%
62,715 $19.2 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $7.01 Million - $8.43 Million
-29,944 Reduced 32.15%
63,189 $15.3 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $32,208 - $41,309
172 Added 0.19%
93,133 $22.4 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $128,117 - $176,047
-735 Reduced 0.78%
92,961 $17.5 Million
Q4 2022

Feb 14, 2023

SELL
$153.06 - $226.57 $2.01 Million - $2.97 Million
-13,125 Reduced 12.29%
93,696 $19.9 Million
Q3 2022

Nov 16, 2022

SELL
$145.13 - $182.49 $1.8 Million - $2.27 Million
-12,424 Reduced 10.42%
106,821 $16.8 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $14.8 Million - $19.1 Million
113,707 Added 2053.21%
119,245 $17.8 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $1.02 Million - $1.57 Million
-7,317 Reduced 56.92%
5,538 $905,000
Q4 2021

Feb 15, 2022

BUY
$182.74 - $227.9 $59,755 - $74,523
327 Added 2.61%
12,855 $2.8 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $3,063 - $3,567
18 Added 0.14%
12,528 $2.37 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $36,165 - $44,300
228 Added 1.86%
12,510 $2.21 Million
Q1 2021

May 18, 2021

SELL
$132.02 - $168.26 $122,118 - $155,640
-925 Reduced 7.0%
12,282 $2.01 Million
Q4 2020

Feb 16, 2021

BUY
$109.38 - $149.19 $302,982 - $413,256
2,770 Added 26.54%
13,207 $1.84 Million
Q3 2020

Nov 16, 2020

SELL
$92.95 - $130.61 $222,615 - $312,810
-2,395 Reduced 18.66%
10,437 $1.17 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $2.36 Million - $3.31 Million
-34,616 Reduced 72.96%
12,832 $1.19 Million
Q4 2019

Feb 12, 2020

SELL
$70.08 - $84.64 $92,365 - $111,555
-1,318 Reduced 2.7%
47,448 $3.99 Million
Q3 2019

Nov 14, 2019

BUY
$62.38 - $85.89 $6,674 - $9,190
107 Added 0.22%
48,766 $4.1 Million
Q2 2019

Aug 13, 2019

BUY
$53.64 - $65.42 $4,613 - $5,626
86 Added 0.18%
48,659 $3.18 Million
Q1 2019

May 14, 2019

BUY
$49.38 - $70.58 $154,065 - $220,209
3,120 Added 6.86%
48,573 $2.86 Million
Q4 2018

Feb 14, 2019

BUY
$46.97 - $63.98 $1.42 Million - $1.93 Million
30,193 Added 197.86%
45,453 $2.41 Million
Q3 2018

Nov 15, 2018

BUY
$43.25 - $63.74 $659,995 - $972,672
15,260 New
15,260 $914,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.